As of 2025-04-26, the Relative Valuation of Pulse Biosciences Inc (PLSE) is (26.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.91 USD, the upside of Pulse Biosciences Inc based on Relative Valuation is -246.1%.
The range of the Relative Valuation is (23.85) - (25.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.9x - 36.2x | 34.5x |
| Forward P/E multiples | 28.0x - 32.2x | 31.2x |
| Fair Price | (23.85) - (25.63) | (26.17) |
| Upside | -233.2% - -243.1% | -246.1% |
| Date | P/E |
| 2025-04-25 | -22.48 |
| 2025-04-24 | -24.19 |
| 2025-04-23 | -22.82 |
| 2025-04-22 | -22.94 |
| 2025-04-21 | -21.71 |
| 2025-04-17 | -22.27 |
| 2025-04-16 | -21.20 |
| 2025-04-15 | -21.38 |
| 2025-04-14 | -20.76 |
| 2025-04-11 | -20.14 |
| 2025-04-10 | -19.53 |
| 2025-04-09 | -19.55 |
| 2025-04-08 | -18.18 |
| 2025-04-07 | -19.03 |
| 2025-04-04 | -18.93 |
| 2025-04-03 | -18.24 |
| 2025-04-02 | -21.00 |
| 2025-04-01 | -20.01 |
| 2025-03-31 | -20.20 |
| 2025-03-28 | -20.84 |
| 2025-03-27 | -19.66 |
| 2025-03-26 | -19.84 |
| 2025-03-25 | -19.90 |
| 2025-03-24 | -20.17 |
| 2025-03-21 | -20.16 |
| 2025-03-20 | -20.35 |
| 2025-03-19 | -21.04 |
| 2025-03-18 | -20.07 |
| 2025-03-17 | -20.15 |
| 2025-03-14 | -21.23 |
| 2025-03-13 | -21.33 |
| 2025-03-12 | -21.50 |
| 2025-03-11 | -21.52 |
| 2025-03-10 | -21.65 |
| 2025-03-07 | -21.81 |
| 2025-03-06 | -21.24 |
| 2025-03-05 | -22.17 |
| 2025-03-04 | -22.31 |
| 2025-03-03 | -22.43 |
| 2025-02-28 | -22.99 |
| 2025-02-27 | -23.02 |
| 2025-02-26 | -24.28 |
| 2025-02-25 | -24.25 |
| 2025-02-24 | -23.55 |
| 2025-02-21 | -24.44 |
| 2025-02-20 | -25.11 |
| 2025-02-19 | -25.45 |
| 2025-02-18 | -27.48 |
| 2025-02-14 | -26.35 |
| 2025-02-13 | -26.88 |